Millions are at a crossroad with the decision to stop weight-loss medications like Wegovy amidst concerns of weight regain and returning to old habits, highlighting the ongoing struggle for many in managing obesity.
Millions who have lost weight through prescription drugs such as Wegovy are finding themselves at a crossroads as they contemplate discontinuing the medication. This debate is fueled by the fear of weight regain and reverting back to previous habits, presenting a challenging situation for many. Clinical trials have shown that stopping the intake of weight-loss drugs often leads to a significant regain of weight, underlining the necessity of continuous treatment for effective results. Despite the success, adherence poses a challenge with only 40% of individuals continuing the medication a year after commencement.
The management of obesity is likened to that of chronic conditions like heart disease by experts, suggesting that it requires persistent treatment efforts. Cutting off the medication may result in an increase in appetite and a reduction in the sensation of fullness, as observed in some patients. Although motivations to taper off the drugs include side effects and financial considerations, medical professionals advise against intermittent usage, given its likely ineffectiveness for the majority.
For patients such as Donna Cooper, who have depended on Wegovy for weight management, the end of medication signifies the beginning of a stringent diet and exercise regimen, marking a new phase in their journey towards health.
